In the 4th quarter of 2020, German based SCHOTT AG, started up a greenfield production plant for pharmaceutical glass tubing in Zhejiang Province, People's Republic of China. The new plant will produce high-quality borosilicate glass tubing – the base material for pharmaceutical packaging such as vials, ampoules, syringes and cartridges, which the vast majority of COVID-19 vaccine projects rely upon.
EME, with the support of our daughter company Shanghai Precision, supplied the Batch Plant incl. Batch Transport and Cullet Return System on a turn-key basis, including building, process equipment and the control system. The batch plant is designed for several furnaces and different glass types.
For the process technology EME adhered to the strict SCHOTT requirements in the dosing, weighing and mixing areas in order to obtain SCHOTT's highest quality pharmaceutical glass.
21.01.2021,
此网站新闻材料的版权属于公司或第三方的新闻提供者，其所有权利保留。所有新闻材料对其访问者只能限于其本人使用，并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供，当应用此新闻材料时，每个使用者都同意遵守，并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.